Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

November 01, 2023 9:08 (London Time)

Delcath Systems

Youtube Subscribe

...

Sector: Medical Devices
Ticker: DCTH
Sentiment: 0.4019
MarketCap: 48,120,934.0
High: 3.28 Low: 3.15

Open: 3.28 Close: 3.15 Change: -0.13

You'll be sorry if you don't use an AI to decide whether to invest in Delcath Systems Stock.

The game is changing. There is a new strategy to evaluate Delcath Systems fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Delcath Systems are: Delcath, Systems, specialize, develop, percutaneous, hepatic, perfusion, …

Concept Map

...

Semantic Network

...

Stock Summary

Delcath Systems, Inc. focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Its lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection.

Today's Summary

Delcath Systems (Delcath) specializes in developing percutaneous hepatic perfusion technologies to treat primary and metastatic liver cancers. Insider Buys additional US$51k In DelcATH Systems stock.

Today's News

Delcath Systems (Delcath) specializes in developing percutaneous hepatic perfusion technologies to treat primary and metastatic liver cancers. Insider Buys additional US$51k In DelcATH Systems stock.

Stock Profile

"Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York."

Keywords

This document will help you to evaluate Delcath Systems without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Delcath Systems are: Delcath, Systems, specialize, develop, percutaneous, hepatic, perfusion, and the most common words in the summary are: system, delcath, approve, inc, health, company, care, . One of the sentences in the summary was: Delcath Systems (Delcath) specializes in developing percutaneous hepatic perfusion technologies to treat primary and metastatic liver cancers. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #system #delcath #approve #inc #health #company #care.

Read more →

Related Results

...
December 20, 2023 1:37 (London Time)

Delcath Systems

Chief Medical Officer Vojo Vukovic Acquires 40,000 shares of Delcath Systems. Chief Medical officer recently increased his stake in the company by p…
Sector: Medical Devices
Ticker: DCTH
Sentiment: 0.8074
MarketCap: 76,279,509.0
High: 3.75 Low: 3.49

Open: 3.49 Close: 3.7 Change: 0.21

Read more →
...
July 13, 2023 20:59 (London Time)

Delcath Systems

StockNews.com upgraded Delcath Systems from a “sell” rating to a ‘hold” in a research report on Friday, May 26th. HC Wainwright decreased their targ…
Sector: Medical Devices
Ticker: DCTH
Sentiment: 0.2732
MarketCap: 58,308,905.0
High: 5.49 Low: 5.05

Open: 5.39 Close: 5.13 Change: -0.26

Read more →
...
November 01, 2023 9:08 (London Time)

Delcath Systems

Delcath Systems (Delcath) specializes in developing percutaneous hepatic perfusion technologies to treat primary and metastatic liver cancers. Insid…
Sector: Medical Devices
Ticker: DCTH
Sentiment: 0.4019
MarketCap: 48,120,934.0
High: 3.28 Low: 3.15

Open: 3.28 Close: 3.15 Change: -0.13

Read more →
...
May 30, 2023 1:24 (London Time)

Delcath Systems

HC Wainwright & co. reiterates buy on delcath systems, maintains $17 price target - delcaint systems inc. (nasdaq:dcth) - benzinga. Reiterates Buy o…
Sector: Medical Devices
Ticker: DCTH
Sentiment: 0.3182
MarketCap: 76,042,507.0
High: 7.72 Low: 7.5

Open: 7.53 Close: 7.71 Change: 0.18

Read more →